Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 4 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 6 hours agoPfizer, Boehringer Ingelheim, Sanofi, and Patheon are also implicated in the cases. In 2020, the US Food and Drug Administration (FDA) ordered the...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Morningstar· 4 days agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent, but stressed that there ...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via AOL· 4 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 4 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Sanofi’s Chronic Lung Disease Drug Gets EU Regulator Backing
Bloomberg· 4 days agoSanofi’s Dupixent is close to being approved in Europe for use in helping patients with a chronic...
Judge Lets More Than 70,000 Zantac Lawsuits Go Forward
Insurance Journal· 12 hours agoThe ruling on Friday by Judge Vivian Medinilla of the Delaware Superior Court in Wilmington is a...
Will Zantac ruling make Delaware a mass torts magnet?
Reuters· 20 hours agoIf you are mass torts lawyer, you should be paying attention to a trend that has emerged in...
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
Fortune via Yahoo Finance· 6 days agoGood morning from Geneva. If generative AI is going to be more than hype and hallucinations, the...